Ip. Casserly et al., USEFULNESS OF ABCIXIMAB FOR TREATMENT OF EARLY CORONARY-ARTERY STENT THROMBOSIS, The American journal of cardiology, 82(8), 1998, pp. 981
The clinical and angiographic outcomes of 10 patients who received abc
iximab as part of their therapy for early stent thrombosis was compare
d with 25 patients (using historical controls) who received convention
al therapy. Although the angiographic outcome and the incidence of myo
cardial infarction in both groups was similar, there were no deaths or
referral for emergency coronary bypass surgery in the abciximab-treat
ed group versus 3 deaths and 10 referrals for emergency bypass surgery
in the conventionally treated group.